Clinical Trial Update: Radiotherapy Treatment Planning Comparison Using SBRT-PATHY (Photons) Versus CARBON-PATHY for Unresectable Bulky Tumors

View source ↗

Summary

A clinical trial evaluating radiotherapy planning for unresectable bulky tumors using SBRT-PATHY (photons) versus CARBON-PATHY has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Snippet

Sponsor: EBG MedAustron GmbH | Conditions: Cancer | Status: WITHDRAWN